Yan Liang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Estrogen Receptor

Positive Breast Cancer

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Chunxiao Sun, Xiang Huang, Jun Li, Ziyi Fu, Yijia Hua, Tianyu Zeng, Yaozhou He, Ningjun Duan, Fan Yang, Yan Liang, Hao Wu, Wei Li, Yuchen Zhang, Yongmei Yin
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer. Cancers 15 (3) (2023)
Chunxiao Sun, Xiang Huang, Jun Li, Ziyi Fu, Yijia Hua, Tianyu Zeng, Yaozhou He, Ningjun Duan, Fan Yang, Yan Liang, Hao Wu, Wei Li, Yuchen Zhang, Yongmei Yin
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer. Cancers 15 (3) (2023)
Zurong Zhai, Yanlin Ren, Chuanjun Shu, Dongyin Chen, Xia Liu, Yan Liang, Aiping Li, Jianwei Zhou
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC. Cell death discovery 8 (1) (2022)
Xueqi Yan, Yaozhou He, Shikun Yang, Tianyu Zeng, Yijia Hua, Shengnan Bao, Fan Yang, Ningjun Duan, Chunxiao Sun, Yan Liang, Ziyi Fu, Xiang Huang, Wei Li, Yongmei Yin
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression. Cell death discovery 8 (1) (2022)
Yan Liang, Chao Qian, Yinghong Xie, Xiang Huang, Junjie Chen, Yanlin Ren, Ziyi Fu, Yongfei Li, Tianyu Zeng, Fan Yang, Jianwei Zhou, Wei Li, Yongmei Yin, Changqing Wang
JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12. Cell death discovery 7 (1) (2021)